Skip to content

13F-HR filed by SAMSARA BIOCAPITAL, LLC

SAMSARA BIOCAPITAL, LLC filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 37 holding rows worth $560,807,077.

Accession
0001415889-25-013106
Filed
2025-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2025

A holdings report, 37 entries on the cover page, a total value of $560,807,077 stated on the cover page (in dollars after the unit check, H1), rows summing to $560,807,077 with VALUE read as dollars as filed, 13F file number 028-19375. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SCHOLAR ROCK HLDG CORP80706P103COM5,612,896$180,454,606dollars as filed
KALARIS THERAPEUTICS INC482929106COM11,448,081$91,928,090dollars as filed
MINERALYS THERAPEUTICS INC603170101COM5,674,916$90,117,666dollars as filed
NEUROGENE INC64135M105COMMON STOCK1,717,127$20,107,557dollars as filed
ALUMIS INC022307102COM3,266,498$20,056,298dollars as filed
PALVELLA THERAPEUTICS INC697947109COMMON STOCK679,486$19,018,813dollars as filed
SEPTERNA INC COM81734D104Stock3,149,128$18,233,451dollars as filed
CARGO THERAPEUTICS INC COM14179K101Stock4,415,689$17,971,854dollars as filed
LENZ THERAPEUTICS INC52635N103COM526,390$13,533,487dollars as filed
UPSTREAM BIO INC91678A107COMMON STOCK2,067,146$12,650,934dollars as filed
ARCELLX INC COMMON STOCK03940C100Stock135,276$8,874,106dollars as filed
ZYMEWORKS INC98985Y108COM666,667$7,940,004dollars as filed
AVADEL PHARMACEUTICALS PLCG29687103COM SHS967,527$7,575,736dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM138,118$7,316,110dollars as filed
NKARTA INC65487U108COMMON STOCK3,768,035$6,933,184dollars as filed
GOSSAMER BIO INC COM38341P102Stock6,130,268$6,743,295dollars as filed
ACELYRIN INC00445A100COM2,523,022$6,231,864dollars as filed
CONTINEUM THERAPEUTICS INC CL A21217B100Stock588,816$4,109,936dollars as filed
VTV THERAPEUTICS INC918385204CL A NEW206,784$3,581,499dollars as filed
ONKURE THERAPEUTICS INC68277Q105COM CL A824,155$3,543,867dollars as filed
SURROZEN INC86889P208COMMON STOCK241,400$2,814,724dollars as filed
ABIVAX SA-00370M103SPONSORED ADS425,000$2,656,250dollars as filed
SUTRO BIOPHARMA INC869367102COM2,196,814$1,429,247dollars as filed
INOZYME PHARMA INC45790W108COM1,562,500$1,421,875dollars as filed
ARTIVA BIOTHERAPEUTICS INC04317A107COM291,666$874,998dollars as filed
TANGO THERAPEUTICS INC87583X109COM630,000$863,100dollars as filed
PRIME MEDICINE INC74168J101COM405,228$806,404dollars as filed
CYPHERPUNK TECHNOLOGIES INC52187K200COM NEW2,442,352$745,162dollars as filed
HILLEVAX INC43157M102COM399,637$579,474dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock202,348$558,480dollars as filed
BOLT BIOTHERAPEUTICS INC097702104COM1,049,153$419,661dollars as filed
CURIS INC231269309COM185,943$390,480dollars as filed
LYRA THERAPEUTICS INC55234L105COM1,390,130$175,573dollars as filed
KRONOS BIO INC50107A104COM78,131$64,458dollars as filed
NUVATION BIO INC67080N119WARR133,333$42,667dollars as filed
ALLAKOS INC01671P100COM172,089$39,167dollars as filed
SURROZEN INC86889P117*W EXP 08/01/20399,999$3,000dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001415889-25-013106this filing2025-05-15acceptance time not in the bulk data set